Test Price
2,800 AED✅ Home Collection Available
MYCN Gene Feingold Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity: ISO 9001:2015 accredited NGS analysis with Sanger confirmation for every pathogenic variant.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test clinical interpretation with a certified genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MYCN Gene Feingold Syndrome Genetic Test detects pathogenic variants in the MYCN gene associated with Feingold syndrome—a congenital malformation disorder. Our test leverages Next-Generation Sequencing (NGS) for comprehensive coverage of all coding exons, splice junctions, and deep intronic regions, delivering unmatched diagnostic accuracy.
| Feature | Our Test (NGS) | Conventional Sanger Sequencing |
|---|---|---|
| Methodology | High-coverage NGS (Illumina® platform) with >100x mean depth, full MYCN gene | Sanger sequencing of selected exons; limited coverage |
| Sample Type | Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) | Whole Blood only, higher volume required |
| Turnaround | 3 to 4 Weeks | 4 to 6 Weeks |
| Variants Detected | SNVs, indels, CNVs, and deep intronic variants | Primarily point mutations and small indels |
| Price (AED) | 2800 | Often comparable but less comprehensive |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I understand that a genetic diagnosis can be emotionally profound. This test must be interpreted alongside clinical findings and family history; a negative result does not exclude all genetic conditions. Always consult with a qualified paediatrician or medical geneticist for comprehensive counselling."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication and Clinical Caution
Do not discontinue or adjust any prescribed medication without consulting your doctor. Genetic testing does not replace ongoing clinical management. All sample collection procedures are performed under strict safety protocols.
Exclusion Criteria & Emergency Red Flags
- Do not proceed with home phlebotomy if you have active infections at the draw site, severe coagulation disorders, or prior adverse reactions to venipuncture.
- If you experience excessive bleeding, fainting, or signs of infection after sample collection, seek emergency medical attention immediately.
- Results are not diagnostic in isolation; in case of acute symptoms, contact your physician or call 998.
Patient FAQ & Clinical Guidance
1. What is the MYCN Gene Feingold Syndrome Genetic Test, and why is it ordered?
The MYCN gene test uses Next-Generation Sequencing to detect all coding and regulatory region mutations linked to Feingold syndrome, aiding accurate diagnosis. It is typically ordered by paediatricians or clinical geneticists for children with microcephaly, digital anomalies, and feeding difficulties, or for family screening and reproductive planning.
2. How should I prepare for the blood sample collection for this genetic test?
No fasting or medication changes are required; simply have your clinical history and a detailed family pedigree ready for the genetic counsellor. If a dried blood spot card is used, a single drop of blood from a finger prick is sufficient. Our VIP mobile phlebotomist will guide you through the entire process at your home or office.
3. What is the turnaround time, and how will I receive my results confidentially in the UAE?
Results are ready in 3 to 4 weeks and delivered through a secure, encrypted online portal, followed by a tele-genetic counselling session. Your data is protected under UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019, ensuring complete confidentiality. You may also request a hard copy via courier.
UAE Regulatory & Data Privacy Adherence
This genetic test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is securely handled and never shared without explicit consent.
Clinical & Logistical Metadata
| Test Name | MYCN Gene Feingold Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 92850-0 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians